DocuSign Inc. logo

DocuSign Inc. (DS3)

Market Closed
5 Jun, 06:02
81. 67
+1.51
+1.88%
- Market Cap
252.44 P/E Ratio
0% Div Yield
0 Volume
1.92 Eps
80.16
Previous Close
Day Range
81.67 81.67
Year Range
44.05 101.6
Earnings results expected in 90 days

Summary

DS3 closed today higher at €81.67, an increase of 1.88% from yesterday's close, completing a monthly increase of 6.05% or €4.66. Over the past 12 months, DS3 stock lost -5.76%.
DS3 is not paying dividends to its shareholders.
The last earnings report, released on 23 hours ago, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Sep 03, 2025.
The stock of the company had never split.
The company's stock is traded on 10 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).
Want to track DS3 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

DS3 Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
DocuSign (DOCU) Reports Q1 Earnings: What Key Metrics Have to Say

DocuSign (DOCU) Reports Q1 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for DocuSign (DOCU) give a sense of how its business performed in the quarter ended April 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Zacks | 37 minutes ago
DocuSign (DOCU) Surpasses Q1 Earnings and Revenue Estimates

DocuSign (DOCU) Surpasses Q1 Earnings and Revenue Estimates

DocuSign (DOCU) came out with quarterly earnings of $0.90 per share, beating the Zacks Consensus Estimate of $0.81 per share. This compares to earnings of $0.82 per share a year ago.

Zacks | 51 minutes ago
Docusign Announces First Quarter Fiscal 2026 Financial Results; Announces $1.0 Billion Increase to Share Repurchase Program

Docusign Announces First Quarter Fiscal 2026 Financial Results; Announces $1.0 Billion Increase to Share Repurchase Program

SAN FRANCISCO , June 5, 2025 /PRNewswire/ -- Docusign, Inc. (NASDAQ: DOCU) today announced results for its fiscal quarter ended April 30, 2025. Prepared remarks and the news release with the financial results will be accessible on Docusign's website at investor.docusign.com prior to its webcast.

Prnewswire | 3 hours ago

DocuSign Inc. Dividends

DS3 is not paying dividends to its shareholders.

DocuSign Inc. Earnings

3 Sep 2025 (90 Days) Date
-
Cons. EPS
-
EPS
5 Jun 2025 5 Jun 2025 Date
-
Cons. EPS
-
EPS
4 Jun 2025 Date
-
Cons. EPS
-
EPS
13 Mar 2025 Date
-
Cons. EPS
-
EPS
5 Mar 2025 Date
-
Cons. EPS
-
EPS
DS3 is not paying dividends to its shareholders.
3 Sep 2025 (90 Days) Date
-
Cons. EPS
-
EPS
5 Jun 2025 5 Jun 2025 Date
-
Cons. EPS
-
EPS
4 Jun 2025 Date
-
Cons. EPS
-
EPS
13 Mar 2025 Date
-
Cons. EPS
-
EPS
5 Mar 2025 Date
-
Cons. EPS
-
EPS

DocuSign Inc. (DS3) FAQ

What is the stock price today?

The current price is €81.67.

On which exchange is it traded?

DocuSign Inc. is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is DS3.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Sep 03, 2025.

Has DocuSign Inc. ever had a stock split?

No, there has never been a stock split.

DocuSign Inc. Profile

Software - Application Industry
Technology Sector
Mr. Allan C. Thygesen CEO
XSTU Exchange
US2561631068 ISIN
US Country
6,838 Employees
- Last Dividend
- Last Split
27 Apr 2018 IPO Date

Overview

DocuSign, Inc. is a pioneering company known for its electronic signature solution, operating both in the United States and internationally. Founded in 2003 and headquartered in San Francisco, California, DocuSign has effectively revolutionized the way agreements are sent and signed across the globe. By integrating its services across various devices, and catering to a broad spectrum of compliance needs, including those of U.S. federal government agencies and life sciences, the company has positioned itself as a key player in digital transaction management. DocuSign sells its innovative products through a combination of direct sales, partner-assisted sales, and digital self-service purchasing methods, showcasing its versatility and commitment to customer convenience and security.

Products and Services

  • E-signature Solution - Enables the electronic sending and signing of agreements on various devices, making transactions more efficient and secure.
  • Contract Lifecycle Management (CLM) - Automates workflows throughout the entire agreement process, enhancing operational efficiency and reducing manual work.
  • Document Generation - Simplifies the creation of custom agreements, streamlining document preparation and saving time.
  • Gen for Salesforce - Allows for the automatic generation of agreements within Salesforce with a few clicks, integrating sales and agreement processes seamlessly.
  • Identify - A signer-identification option providing an extra layer of security by checking government-issued IDs.
  • Standards-Based Signatures - Supports digital signatures that involve digital certificates, catering to specific legal and regulatory requirements.
  • Monitor - Utilizes advanced analytics to track the usage of DocuSign eSignature web, mobile, and API account, enhancing oversight and management.
  • Notary - Enables notaries public to conduct remote online notarization transactions, broadening the scope of digital agreements.
  • Web Forms - Creates web forms to quickly draft agreements using data from completed forms or external systems via APIs, increasing efficiency.
  • Rooms for Real Estate - Offers a digital platform for brokers and agents to manage the entire real estate transaction process, from start to finish.
  • FedRAMP Authorized eSignature - An authorized version of DocuSign eSignature for U.S. federal government agencies, ensuring compliance with strict security standards.
  • Life Sciences Modules - Supports compliance with the electronic signature practices in the life sciences industry, addressing sector-specific regulatory requirements.

Contact Information

Address: 221 Main Street
Phone: 415 489 4940